COX-2 inhibitors still promising for prostate Ca: celecoxib slowed down the rise in PSA doubling, with no apparent renal or cardiovascular side effects.(Urology): ... An article from: Internal Medicine News [HTML] (Digital) Product Details: Format: HTMLPrintable: YesMac OS Compatible: YesWindows Compatible: YesHandheld Compatible: YesFile Size: 5 KBDigital: 3 pagesPublisher: International Medical News Group (August 1, 2005)Required Free Software: Any web browser
|
|  $5.95
|
|